Navigation Links
Journal of Hospice & Palliative Nursing Names New Editor
Date:11/13/2009

nursing organization dedicated to promoting excellence in hospice and palliative nursing care. HPNA members work in the specialty of palliative nursing across the life span continuum, and include advanced practice nurses, registered nurses, licensed practical nurses, and nursing assistants who care for people with life-limiting and terminal illness.

Provided by Newswise, online resource for knowledge-based news at www.newswise.com

    Media Contacts:
    Natalie McGroarty
    Senior Marketing Manager
    Wolters Kluwer Health
    +1 (215) 628-7759
    natalie.mcgroarty@wolterskluwer.com

    Robert Dekker
    Director of Communications
    Wolters Kluwer Health
    +1 (215) 521-8928
    Robert.Dekker@wolterskluwer.com

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins


'/>"/>
SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2015)... ... September 05, 2015 , ... Doctors in Chicago have published a new study ... patients. Surviving Mesothelioma has just posted an article on the research on its website. ... of Chicago performed a retrospective analysis of 117 mesothelioma patients who underwent extended pleurectomy ...
(Date:9/4/2015)... , ... September 04, 2015 , ... According to an ... Americans currently being cared for in nursing homes and assisted living facilities are receiving ... a personal story in which her father was at one point close to death, ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Mile High Connects ... in which a lack of funding for sidewalks, bike paths, and other vital supports ... while the Denver region spends billions of dollars to expand public transit, there’s very ...
(Date:9/4/2015)... ... September 04, 2015 , ... After wearing the same uniforms for six seasons, ... In an effort to assist the team, the Jones Agency, a locally owned insurance ... raise funds for the new uniforms. , As is so often the case with ...
(Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
Breaking Medicine News(10 mins):Health News:New Study Appears to Validate the Safety of Mesothelioma Surgery for Older Patients, According to Surviving Mesothelioma 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... , , , , ... Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest ... on the proliferative ability of stem cells found in menstrual blood ... 8-10 in Dalian, China. Data from an in vitro study show ...
... , , ( ) , , ... PARAMUS, N.J., Aug. 6 Smart Balance, Inc. (Nasdaq: SMBL ) ... reported net sales of $58.2 million, an increase of 21.2% versus year ago, and earnings ... , , The second quarter net sales increase versus 2008 was due ...
... is no cure, survey finds , THURSDAY, Aug. 6 (HealthDay ... that daily medicine can be taken to prevent a food ... lack of knowledge and awareness about food allergy among the ... found that nearly half of respondents incorrectly believed that there ...
... choosing it for their animal companions , THURSDAY, Aug. 6 ... as more animal owners are making that choice for their ... For nearly 20 years, a handful of veterinarians has helped ... failure, to die peacefully at home, not in a ...
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Aug. 6 ... of surveyed pharmacy directors say that by 2014 they ... preferred biologic for all immune conditions, such as rheumatoid ... the new Formulary Forum report entitled Formulary Advantages ...
... , , , ... a hospitalist management company, presented performance improvement and cost savings ... Services during the recent American Hospital Association (AHA) Leadership Summit. ... President, Medical Affairs at Reid, presented average three-month-trend results of ...
Cached Medicine News:Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 3Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 4Health News:Smart Balance Announces 2009 Second Quarter Results 2Health News:Smart Balance Announces 2009 Second Quarter Results 3Health News:Smart Balance Announces 2009 Second Quarter Results 4Health News:Smart Balance Announces 2009 Second Quarter Results 5Health News:Smart Balance Announces 2009 Second Quarter Results 6Health News:Smart Balance Announces 2009 Second Quarter Results 7Health News:Smart Balance Announces 2009 Second Quarter Results 8Health News:Smart Balance Announces 2009 Second Quarter Results 9Health News:Smart Balance Announces 2009 Second Quarter Results 10Health News:Food Allergy Facts Need More Focus 2Health News:Hospice Care Eases the End for Loyal Pets 2Health News:Hospice Care Eases the End for Loyal Pets 3Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 2Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 3Health News:Inpatient Management, Inc. and Reid Hospital Achieve Performance Improvement and Cost Savings 2
(Date:9/4/2015)... , Sep. 04, 2015 ... announced the addition of the "Veterinary Pharmaceutical ... 7-8, 2015)" conference to their offering. ... through all of the constituent parts of the ... product for which a marketing authorisation is sought ...
(Date:9/4/2015)... MENLO PARK, Calif. , Sept. 4, 2015 ... and the "Company"), a biopharmaceutical company focused on the ... its financial results for the fiscal year ending June ... highlights and expected near-term milestones. DelMar,s ... and live webcast for investors, analysts and other interested ...
(Date:9/3/2015)... LONDON , Sept. 3, 2015 ... ophthalmic devices market? Which areas are going to grow ... you potential revenues to 2025, assessing data, trends, opportunities ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... EMERYVILLE, Calif. , June 14 Bayer HealthCare ... announced that the final analysis of the Phase 3 NExUS ... S orafenib) trial evaluating Nexavar® (sorafenib) tablets in patients ... the study did not meet its primary endpoint of improving ...
... YORK , June 12 /PRNewswire-Asia/ -- In honor of ... and,children can bring it home for parents to monitor body fat daily. ... ... coming Father,s Day , medicalequipmentpro.com has,launched a special promotion since ...
Cached Medicine Technology:Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 2Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 3Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 4Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 5Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 6Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival 7Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 2Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 3Father's Day Promotion of Body Fat Monitors Continues on Medicalequipmentpro.com 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: